Tools and technologies enabling healthcare
1 known investors
Stemnovate provides an integrated platform combining multiomics data, cell reprogramming technology, and mechanistic functional studies to accelerate drug discovery and clinical translation for rare diseases, neurodegenerative conditions, and other therapeutic areas across human and animal health. The company operates cellular biobanks, develops microphysiological systems for in vitro testing, and partners with pharmaceutical and academic institutions to reduce reliance on animal testing while enabling precision medicine research.